Back
argenx SE 10K Form
Sell
50
ARGX
argenx SE
Last Price:
$746.93
Seasonality Move:
16.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ARGX News And Ratings
See the #1 stock for the next 7 days that we like better than ARGX
ARGX Financial Statistics
Sales & Book Value
| Annual Sales: | $4.2B |
|---|---|
| Cash Flow: | $312.8M |
| Price / Cash Flow: | 67.37 |
| Annual Sales: | $99.66 |
| Price / Book: | 6.4 |
Profitability
| EPS (TTM): | 19.58370 |
|---|---|
| Net Income (TTM): | $1.3B |
| Gross Margin: | $3.7B |
| Return on Equity: | 28.06% |
| Return on Assets: | 21.14% |
argenx SE Earnings Forecast
Key argenx SE Financial Ratios
-
The Gross Profit Margin over the past 15 years for ARGX is 88.67%.
-
The Selling, General & Administrative Expenses for ARGX have been equal to 32.91% of Gross Profit Margin.
-
The Research & Development expenses have been 32.54% of Revenue.
-
The Interest Expense is 0.32% of Operating Income.
-
The Net Earning history of ARGX is 31.11% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 6 years.
argenx SE Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ARGX |
| CUSIP: | 04016X |
| Website: | argen-x.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.6 |
| Quick Ratio: | 4.92 |
Price-to-Earnings
| Trailing P/E Ratio: | 38.22 |
|---|---|
| Forward P/E Ratio: | 22.49 |